News Aug 20, 2025
Porton Nominated for the 2025 Sedex Supply Chain Award
Porton Pharma Solutions Ltd. (“Porton”) was honored with a nomination for the Positive Endeavors Award at the 2025 Sedex Supply Chain Award Ceremony. The recognition highlights Porton’s unwavering commitment to sustainability and responsible business practices.
News Aug 19, 2025
Porton to Showcase Integrated CDMO Expertise at CPHI Frankfurt 2025
The 2025 CPhI Frankfurt event will take place from October 28–30 at Messe Frankfurt, Germany, gathering over 62,000 attendees and 2,400 exhibitors from more than 166 countries.
NewslettersAug 04, 2025
Porton Newsletter - July 2025 Recap
Technical Enabling Services & Solutions Company Events Marketing Activities
News Jul 31, 2025
NMPA Approves Jike Shu (Sebaloxavir Marboxil Tablets) for the Treatment of Uncomplicated Influenza in Adults
Self-developed novel PA endonuclease inhibitor anti-influenza drug Jike Shu (Sebaloxavir Marboxil Tablets) has officially received marketing approval from China's National Medical Products Administration (NMPA) for the treatment of uncomplicated influenza in adults.
News Jul 31, 2025
Porton Participates in Publishing an OPRD Paper, Demonstrating Strength in Drug Synthesis Technology
Metal catalytic and DoE technologies for the optimization of CT1812 synthesis routes
News Jul 31, 2025
Porton and Repare Therapeutics Collaborate on OPRD Publication, Demonstrating Strength in Synthetic Process Development and Optimization
Overcoming the challenge of efficient synthesis of PKMYT1 inhibitor Lunresertib
News Jul 30, 2025
Porton Provides Support for Mednovo's RDC Drug IND
Recently, Porton Pharma Solutions Ltd. (Porton) was awarded the "2024-2025 Excellent Supplier Award" by Mednovo Group Co., Ltd. (Mednovo Group) in recognition of Porton’s professional support in the R&D of Radionuclide-Drug Conjugate (RDC).
NewslettersJul 08, 2025
Porton Newsletter - Q2 2025 Recap
Technical Enabling Services & Solutions Company Events ESG Marketing Activities
NewslettersJul 04, 2025
Porton Newsletter - June 2025 Recap
Technical Enabling Services & Solutions Company Events ESG Marketing Activities
